Literature DB >> 9655604

Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes.

D A Gurley1, T H Lanthorn.   

Abstract

The 5-HT3 receptor (5-HT3R) is part of a superfamily of ligand-gated ion channels which includes nicotinic acetylcholine receptors (nAChR). cRNA derived from the long isoform cloned mouse 5-HT3R was used to drive expression of 5-HT3Rs in Xenopus oocytes. 5-HT-induced currents were monitored using two-electrode voltage-clamp. Eight nicotinic agonists, including ACh and nicotine, but not alpha-anatoxin, were found to antagonize 5-HT-induced currents. With the exception of 3-(2,4)-dimethoxybenzylidene-anabaseine (DMXB-anabaseine; GTS-21) this antagonism appeared to be competitive since it could be overcome by increasing concentrations of 5-HT. Potency of 5-HT3 antagonism was comparable to reported values for nAChR alpha7 activation. These results confirm the notion of families of receptors and further indicate that strong similarities can exist in some critical binding domains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655604     DOI: 10.1016/s0304-3940(98)00306-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.

Authors:  A J Thompson; M H P Verheij; I J P de Esch; S C R Lummis
Journal:  J Pharmacol Exp Ther       Date:  2012-02-03       Impact factor: 4.030

2.  MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay.

Authors:  Małgorzata Dukat; Anna Wesołowska; Genevieve Alley; Shawquia Young; Galya R Abdrakhmanova; Hernán A Navarro; Richard Young; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2010-04-30       Impact factor: 4.530

3.  A triad of residues is functionally transferrable between 5-HT3 serotonin receptors and nicotinic acetylcholine receptors.

Authors:  Richard Mosesso; Dennis A Dougherty
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

4.  BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.

Authors:  Dalton King; Christiana Iwuagwu; Jim Cook; Ivar M McDonald; Robert Mate; F Christopher Zusi; Matthew D Hill; Haiquan Fang; Rulin Zhao; Bei Wang; Amy E Easton; Regina Miller; Debra Post-Munson; Ronald J Knox; Lizbeth Gallagher; Ryan Westphal; Thaddeus Molski; Jingsong Fan; Wendy Clarke; Yulia Benitex; Kimberley A Lentz; Rex Denton; Daniel Morgan; Robert Zaczek; Nicholas J Lodge; Linda J Bristow; John E Macor; Richard E Olson
Journal:  ACS Med Chem Lett       Date:  2017-02-08       Impact factor: 4.345

5.  Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.

Authors:  Matthew D Hill; Haiquan Fang; H Dalton King; Christiana I Iwuagwu; Ivar M McDonald; James Cook; F Christopher Zusi; Robert A Mate; Ronald J Knox; Debra Post-Munson; Amy Easton; Regina Miller; Kimberley Lentz; Wendy Clarke; Yulia Benitex; Nicholas Lodge; Robert Zaczek; Rex Denton; Daniel Morgan; Linda Bristow; John E Macor; Richard Olson
Journal:  ACS Med Chem Lett       Date:  2016-12-01       Impact factor: 4.345

6.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

7.  Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.

Authors:  Asti Jackson; Roger L Papke; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

8.  Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine.

Authors:  Sheketha R Hauser; Amy L Bracken; Gerald A Deehan; Jamie E Toalston; Zheng-Ming Ding; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Addict Biol       Date:  2013-03-18       Impact factor: 4.280

Review 9.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

10.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.